Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin

Details for Australian Patent Application No. 2006257428 (hide)

International Classifications

Event Publications

31 January 2008 PCT application entered the National Phase

PCT publication WO2006/133835 Priority application(s): WO2006/133835

22 March 2012 Application Accepted

Published as AU-B-2006257428

26 April 2012 Application for Amendment

The nature of the amendment is: Amend the invention title to read Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

16 August 2012 Amendment Made

The nature of the amendment is: Amend the invention title to read Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.